Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ.

Identifying the extent of apoptosis in cells or tissues after cancer therapy in real time would be a powerful firsthand tool for assessing therapeutic outcome. We combined therapeutic and imaging functions in one agent, choosing photodynamic therapy (PDT) as an appropriate cancer treatment modality. This agent induces photodamage in irradiated cells and simultaneously identifies apoptotic cells by near-infrared fluorescence. This photodynamic therapy agent with a built-in apoptosis sensor (PDT-BIAS) contains a fluorescent photosensitizer used as an anticancer drug, connected to a fluorescence quencher by a caspase-3 cleavable peptide linker. We demonstrated that cleavage of the peptide linker by caspase-3, one of the executioner caspases involved in apoptosis, results in a detectable increase of fluorescence in solution and in cancer cells after PDT treatment. The apoptosis involvement and drug effectiveness were confirmed by Apoptag and cell viability (MTT) assays supporting the ability of PDT-BIAS to induce and image apoptosis in situ.

[1]  G. Gores,et al.  Apoptosis in cancer: cause and cure , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  N. Oleinick,et al.  Dissociation of mitochondrial depolarization from cytochrome c release during apoptosis induced by photodynamic therapy , 2001, British Journal of Cancer.

[3]  R. Weissleder,et al.  Near-infrared fluorescent imaging of tumor apoptosis. , 2003, Cancer research.

[4]  D. Kessel Relocalization of cationic porphyrins during photodynamic therapy , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[5]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[6]  R. Weissleder,et al.  An azulene dimer as a near-infrared quencher. , 2002, Angewandte Chemie.

[7]  D. Kessel,et al.  The Role of Subcellular Localization in Initiation of Apoptosis by Photodynamic Therapy , 1997, Photochemistry and photobiology.

[8]  H. Jaeschke,et al.  Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  S. Van Cruchten,et al.  Morphological and biochemical aspects of apoptosis, oncosis and necrosis. , 2002 .

[10]  A. Toren,et al.  A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy , 1999, British Journal of Cancer.

[11]  T. Dougherty,et al.  Subcellular Localization Patterns and Their Relationship to Photodynamic Activity of Pyropheophorbide‐a Derivatives , 1999, Photochemistry and photobiology.

[12]  M S Patterson,et al.  The physics of photodynamic therapy. , 1986, Physics in medicine and biology.

[13]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[14]  C. Reutelingsperger,et al.  Flow cytometry of apoptotic cell death. , 2000, Journal of immunological methods.

[15]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[16]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[17]  Ramiro D. Almeida,et al.  Intracellular signaling mechanisms in photodynamic therapy. , 2004, Biochimica et biophysica acta.

[18]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[19]  K. Bullok,et al.  Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. , 2005, Journal of medicinal chemistry.

[20]  Kashif Azizuddin,et al.  Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy. , 2003, Cancer research.

[21]  Nancy L Oleinick,et al.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[22]  H. Schild,et al.  Apoptosis: the complex scenario for a silent cell death. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[23]  A. S. Sobolev,et al.  Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency , 2000, Immunology and cell biology.

[24]  D. Kessel,et al.  Photodynamic therapy: A mitochondrial inducer of apoptosis , 1999, Cell Death and Differentiation.

[25]  Britton Chance,et al.  Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. , 2004, Journal of the American Chemical Society.

[26]  Hector Nava,et al.  Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. , 2003, Cancer research.

[27]  A. Wardlaw,et al.  A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. , 1998, Journal of immunological methods.

[28]  Britton Chance,et al.  Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. , 2003, Bioconjugate chemistry.

[29]  R. Voll,et al.  Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance , 2005, Cell Death and Differentiation.

[30]  Brian C. Wilson,et al.  Direct Near‐infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo ¶ , 2002 .

[31]  W. Leung,et al.  Photodynamic Therapy with Pyropheophorbide-a Methyl Ester in Human Lung Carcinoma Cancer Cell: Efficacy, Localization and Apoptosis¶ , 2002 .

[32]  A. Moor,et al.  Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.

[33]  N. Oleinick,et al.  The photobiology of photodynamic therapy: cellular targets and mechanisms. , 1998, Radiation research.